Overview
Guoming Chen practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Legg-Calve-Perthes Disease (LCPD), Biliary Atresia, Osteonecrosis, and Hepatitis B.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Guoming Chen
Is Guoming Chen a top-rated expert for Legg-Calve-Perthes Disease (LCPD)?
MediFind is an objective health platform that identifies experts based on real-world data. Guoming Chen is classified as an Experienced expert for Legg-Calve-Perthes Disease (LCPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Guoming Chen participate in research or clinical trials?
Yes. Guoming Chen has published 14 articles and abstracts on conditions like Legg-Calve-Perthes Disease (LCPD). You can view a list of Guoming Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Biliary AtresiaChen isExperienced. Learn about Biliary Atresia.
- Hepatitis BChen isExperienced. Learn about Hepatitis B.
- Legg-Calve-Perthes Disease (LCPD)
- OsteonecrosisChen isExperienced. Learn about Osteonecrosis.